{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:10:34Z","timestamp":1776831034580,"version":"3.51.2"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jclinepi.2019.04.019","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T12:12:33Z","timestamp":1556799153000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Applying sequential surveillance methods that use regression adjustment or weighting to control confounding in a multisite, rare-event, distributed setting: Part 2 in-depth example of a reanalysis of the measles-mumps-rubella-varicella combination vaccine and seizure risk"],"prefix":"10.1016","volume":"113","author":[{"given":"Andrea J.","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1435-6134","authenticated-orcid":false,"given":"Robert D.","family":"Wellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6865-5092","authenticated-orcid":false,"given":"Tracey","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Shoaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2019.04.019_bib1","series-title":"The future of drug safety: promoting and protecting the health of the public","year":"2007"},{"key":"10.1016\/j.jclinepi.2019.04.019_bib2","series-title":"U.S.P.L., 110th Cong. 2008","article-title":"Food and Drug Administration Amendments Act of 2007","year":"2011"},{"issue":"2","key":"10.1016\/j.jclinepi.2019.04.019_bib3","first-page":"186","article-title":"The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA","volume":"78","author":"Chen","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"Suppl 1","key":"10.1016\/j.jclinepi.2019.04.019_bib4","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jclinepi.2019.04.019_bib5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJMp1014427","article-title":"Developing the sentinel system--a national resource for evidence development","volume":"364","author":"Behrman","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl1","key":"10.1016\/j.jclinepi.2019.04.019_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.2323","article-title":"The Food and drug administration's post-licensure rapid immunization safety monitoring program: strengthening the federal vaccine safety enterprise","volume":"21","author":"Nguyen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Suppl 1","key":"10.1016\/j.jclinepi.2019.04.019_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/pds.2337","article-title":"A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent","volume":"21","author":"Fireman","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Suppl 1","key":"10.1016\/j.jclinepi.2019.04.019_bib8","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1542\/peds.2010-1722I","article-title":"Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project","volume":"127","author":"Yih","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jclinepi.2019.04.019_bib9","series-title":"Mini-sentinel prospective routing observational monitoring program tools (PROMPT): Rivaroxaban surveillance","author":"Carnahan","year":"2015"},{"issue":"2","key":"10.1016\/j.jclinepi.2019.04.019_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/rssc.12076","article-title":"Group sequential method for observational data by using generalized estimating equations: application to Vaccine Safety Datalink","volume":"64","author":"Cook","year":"2014","journal-title":"J R Stat Soc Ser C Appl Stat"},{"key":"10.1016\/j.jclinepi.2019.04.019_bib11","series-title":"Statistical methods for estimating causal risk differences in the distributed data setting for postmarket safety outcomes","author":"Cook","year":"2012"},{"issue":"1","key":"10.1016\/j.jclinepi.2019.04.019_bib12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"issue":"34","key":"10.1016\/j.jclinepi.2019.04.019_bib13","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting","volume":"27","author":"Jacobsen","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jclinepi.2019.04.019_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/biomet\/64.2.191","article-title":"Group sequential methods in the design and analysis of clincial trials","volume":"64","author":"Pocock","year":"1977","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.jclinepi.2019.04.019_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.jclinepi.2019.04.019_bib16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.0006-341X.1999.00874.x","article-title":"A unifying family of group sequential test designs","volume":"55","author":"Kittelson","year":"1999","journal-title":"Biometrics"},{"key":"10.1016\/j.jclinepi.2019.04.019_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"key":"10.1016\/j.jclinepi.2019.04.019_bib18","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1002\/sim.2901","article-title":"Frequentist evaluation of group sequential clinical trial designs","volume":"26","author":"Emerson","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2019.04.019_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/aje\/kws317","article-title":"Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study","volume":"177","author":"Nelson","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2019.04.019_bib20","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/sim.1903","article-title":"Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study","volume":"23","author":"Lunceford","year":"2004","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.jclinepi.2019.04.019_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/07474946.2011.539924","article-title":"A maximized sequential probability ratio test for drug and vaccine safety surveillance","volume":"30","author":"Kulldorff","year":"2011","journal-title":"Seq Anal"},{"issue":"5\u20136","key":"10.1016\/j.jclinepi.2019.04.019_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.vaccine.2003.09.008","article-title":"Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jclinepi.2019.04.019_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1081\/BIP-120037195","article-title":"Conditional bias of point estimates following a group sequential test","volume":"14","author":"Fan","year":"2004","journal-title":"J Biopharm Stat"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435617314142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435617314142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T05:16:17Z","timestamp":1760246177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435617314142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":23,"alternative-id":["S0895435617314142"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2019.04.019","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applying sequential surveillance methods that use regression adjustment or weighting to control confounding in a multisite, rare-event, distributed setting: Part 2 in-depth example of a reanalysis of the measles-mumps-rubella-varicella combination vaccine and seizure risk","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2019.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2019.04.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}